Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Am J Transplant. 2020 Nov 20;21(6):2113–2122. doi: 10.1111/ajt.16388

Table 4:

Cytokine Concentration by Transplant Status

Cytokine Concentration (by Transplant Status)
Transplant GNB (N=29) Non- Transplant GNB (N=30) p value Transplant SAB (N=26) Non-Transplant GNB (N=30) p value
Eotaxin, Median (IQR) 34.9 (23.4, 39.9) 37.8 (24.5, 44.0) 0.511 52.7 (32.5, 87.4) 54.9 (39.9, 89.4) 0.851
IFN-α, Median (IQR) 5.1 (5.1, 5.1) 5.1 (5.1, 26.3) 0.041 5.1 (5.1, 36.4) 5.1 (5.1, 24.0) 0.381
IL-1RA, Median (IQR) 331.3 (194.4, 699.8) 566.1 (365.4, 1826.0) 0.061 842.2 (411.9, 1712.8) 748.7 (509.9, 1942.2) 0.791
IL-10, Median (IQR) 6.0 (6.0, 6.0) 6.0 (6.0, 6.0) 0.671 6.0 (6.0, 34.2) 6.0 (6.0, 33.3) 0.801
IL-12, Median (IQR) 81.6 (47.3, 134.4) 68.6 (34.3, 103.2) 0.401 84.8 (40.6, 235.6) 138.3 (75.0, 333.0) 0.191
IL-15, Median (IQR) 12.0 (12.0, 12.0) 12.0 (12.0, 126.7) 0.031 11.3 (11.3, 92.4) 11.3 (11.3, 92.4) 0.911
IL-2, Median (IQR) 7.1 (7.1, 7.1) 32.6 (7.1, 88.0) 0.0011 6.9 (6.9, 95.9) 28.6 (6.9, 98.8) 0.861
IL-2R, Median (IQR) 74.6 (28.5, 189.1) 134.3 (28.5, 298.4) 0.461 266.9 (120.8, 467.4) 221.1 (28.4, 330.6) 0.481
IL-6, Median (IQR) 25.9 (3.5, 86.5) 38.7 (15.8, 97.2) 0.211 56.2 (15.6, 97.7) 72.7 (34.0, 102.3) 0.281
IL-8, Median (IQR) 32.0 (5.6, 53.1) 59.1 (39.2, 119.4) 0.0031 84.4 (38.7, 114.8) 103.0 (62.5, 254.4) 0.091
IP-10, Median (IQR) 6.8 (4.2, 12.7) 6.2 (3.8, 11.9) 0.741 6.9 (4.3, 16.2) 10.1 (3.9, 17.1) 0.801
MCP-1, Median (IQR) 496.5 (291.1, 728.4) 448.6 (355.8, 807.7) 0.841 736.5 (412.7, 1142.8) 912.7 (469.2, 1458.9) 0.511
MIG, Median (IQR) 82.7 (65.2, 226.0) 75.9 (13.1, 139.1) 0.431 204.6 (72.0, 357.1) 149.1 (94.0, 211.7) 0.361
MIP-1α, Median (IQR) 8.9 (8.9, 8.9) 8.9 (8.9, 8.9) 0.211 8.8 (8.8, 49.1) 8.8 (8.8, 44.8) 0.861
MIP-1β, Median (IQR) 30.7 (30.7, 30.7) 243.3 (30.7, 344.4) 0.0011 193.6 (88.0, 362.7) 234.3 (131.0, 444.8) 0.291
RANTES, Mean (SD) 544.8 (106.5) 523.4 (137.3) 0.512 750.2 (194.6) 656.5 (147.6) 0.0462
GM-CSF, Median (IQR) 3.5 (3.5, 3.5) 3.5 (3.5, 3.5) 0.621 3.5 (3.5, 3.5) 3.5 (3.5, 3.5) 0.321
IFN-γ, Median (IQR) 3.0 (3.0, 3.0) 3.0 (3.0, 3.0) 0.341 3.0 (3.0, 3.0) 3.0 (3.0, 3.0) 0.381
IL-1β, Median (IQR) 6.1 (6.1, 6.1) 6.1 (6.1, 6.1) 0.331 6.0 (6.0, 6.0) 6.0 (6.0, 6.0) 0.291
IL-13, Median (IQR) 7.2 (7.2, 7.2) 7.2 (7.2, 7.2) .2 6.9 (6.9, 6.9) 6.9 (6.9, 6.9) 0.921
IL-17A, Median (IQR) 14.9 (14.9, 14.9) 14.9 (14.9, 14.9) .2 14.9 (14.9, 14.9) 14.9 (14.9, 14.9) 0.301
IL-4, Median (IQR) 31.4 (31.4, 31.4) 31.4 (31.4, 31.4) 0.331 30.6 (30.6, 30.6) 30.6 (30.6, 30.6) 0.731
IL-5, Median (IQR) 5.1 (5.1, 5.1) 5.1 (5.1, 5.1) .2 5.0 (5.0, 5.0) 5.0 (5.0, 5.0) .2
IL-7, Median (IQR) 9.4 (9.4, 9.4) 9.4 (9.4, 9.4) 0.321 9.0 (9.0, 9.0) 9.0 (9.0, 9.0) 0.291
TNF-α, Median (IQR) 2.9 (2.9, 2.9) 2.9 (2.9, 2.9) 0.331 2.8 (2.8, 2.8) 2.8 (2.8, 2.8) 0.921

GNB, gram-negative bacteremia; SAB, S. aureus bacteremia;

1

Wilcoxon

2

Equal Variance T-Test